Abstract
The in vivo effects of LMS were studied in 9 patients with A-T for a two month period. Among the various immunological parameters investigated following treatment with LMS, only the total lymphocyte count and the absolute number of E rosettes were found to be increased and serum IgM levels were reduced.
Keywords: ataxia-telangiectasia, hereditary immunodeficiency, levamisole therapy
Copyright and license
Copyright © 1981 The Author(s). This is an open access article distributed under the Creative Commons Attribution License (CC BY), which permits unrestricted use, distribution, and reproduction in any medium or format, provided the original work is properly cited.
How to cite
1.
Levendoğlu O, Berkel Aİ, Ersoy F, Sanal Ö. Levamisole therapy in ataxia-telangiectasia. Turk J Pediatr 1981; 23: 255-259. https://doi.org/10.24953/turkjpediatr.1981.4138
